{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:32Z","timestamp":1793500532722,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adult-onset immunodeficiency (AOID) mediated by anti-interferon-\u03b3 autoantibodies (AIGA) is a rare condition, particularly prevalent in Southeast Asia and southern China. We present a case study of a 62-year-old female with AOID who developed a severe pulmonary infection caused by <jats:italic>Talaromyces marneffei<\/jats:italic> (TM), leading to acute respiratory failure, generalized rash, multiple lymphadenopathies, bone destruction, and a mediastinal mass. Treatment included mechanical ventilation, antifungal medication, and corticosteroids, resulting in complete recovery and discharge. This case underscores the challenges of managing complex infections in AOID patients and highlights the importance of early diagnosis through metagenomic next-generation sequencing (mNGS) and appropriate intervention to improve clinical outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1430179","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:37:21Z","timestamp":1725856641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Systemic multi-organ involvement in an adult-onset immunodeficiency patient infected with Talaromyces marneffei"],"prefix":"10.3389","volume":"15","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-gamma autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1684 e1","DOI":"10.1016\/j.cmi.2020.02.030","article-title":"Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies","volume":"26","author":"Wu","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-\u03b3 Neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-\u03b3 Autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in northern Thailand","volume":"8","author":"Rottenberg","year":"2013","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S337956","article-title":"Retrospective analysis of 10 cases of disseminated nontuberculous mycobacterial disease with osteolytic lesions","volume":"14","author":"Tang","year":"2021","journal-title":"Infect Drug Resist"},{"key":"B14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12879-021-06255-9","article-title":"Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-gamma immunodeficiency: a prospective cohort study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1038\/s41598-022-13160-x","article-title":"Clinical findings and predictive factors for positive anti-interferon-gamma autoantibodies in patients suffering from a non-tuberculosis mycobacteria or Talaromyces marneffei infection: a multicenter prospective cohort study","volume":"12","author":"Qiu","year":"2022","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-gamma autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00053-10","article-title":"Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon","volume":"17","author":"Tang","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01537-0","article-title":"Characteristics and outcomes of anti-interferon gamma antibody-associated adult onset immunodeficiency","volume":"43","author":"Zhang","year":"2023","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","article-title":"Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects","volume":"19","author":"Vanittanakom","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-48-11-973","article-title":"Penicilliosis marneffei\u2013West meets East","volume":"48","author":"Wong","year":"1999","journal-title":"J Med Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","article-title":"Penicillium marneffei infection: an emerging disease in mainland China","volume":"175","author":"Hu","year":"2013","journal-title":"Mycopathologia"},{"key":"B23","article-title":"Penicillosis from rhizomys sinensis","volume":"49","author":"Capponi","year":"1956","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/02681218680000581","article-title":"Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus)","volume":"24","author":"Deng","year":"1986","journal-title":"J Med Vet Mycol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/60.2.259","article-title":"Infection caused by Penicillium marneffei: description of first natural infection in man","volume":"60","author":"DiSalvo","year":"1973","journal-title":"Am J Clin Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.1.125","article-title":"Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases","volume":"23","author":"Duong","year":"1996","journal-title":"Clin Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.18","article-title":"Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3201\/eid1702.100718","article-title":"Common reservoirs for Penicillium marneffei infection in humans and rodents, China","volume":"17","author":"Cao","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0909","article-title":"Case report: successful treatment of pulmonary talaromyces marneffei infection with posaconazole in a renal transplant recipient","volume":"104","author":"Lang","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03983-22","article-title":"The real-world clinical impact of plasma mNGS testing: an observational study","volume":"11","author":"Han","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03060-15","article-title":"Unbiased detection of respiratory viruses by use of RNA sequencing-based metagenomics: a systematic comparison to a commercial PCR panel","volume":"54","author":"Graf","year":"2016","journal-title":"J Clin Microbiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.09.004","article-title":"Next generation sequencing for diagnosis of severe pneumonia: China, 2010-2018","volume":"78","author":"Xie","year":"2019","journal-title":"J Infect"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2021.09.012","article-title":"Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections","volume":"38","author":"Diao","year":"2022","journal-title":"J Adv Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00051-22","article-title":"An overlooked and underrated endemic mycosis-talaromycosis and the pathogenic fungus talaromyces marneffei","volume":"36","author":"Wang","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/idr.S364388","article-title":"Anti-interferon-\u03b3 Autoantibodies impair T-lymphocyte responses in patients with talaromyces marneffei infections","volume":"15","author":"Chen","year":"2022","journal-title":"Infection Drug Resistance"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001644","article-title":"Neutralizing antiinterferon-\u03b3 autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy","volume":"31","author":"Wu","year":"2017","journal-title":"Aids"},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-gamma autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6473629","article-title":"Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated mycobacterium abscessus infection","volume":"2018","author":"Chetchotisakd","year":"2018","journal-title":"J Immunol Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa035","article-title":"Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-gamma autoantibodies","volume":"7","author":"Laisuan","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100102","DOI":"10.1016\/j.jtauto.2021.100102","article-title":"Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies","volume":"4","author":"Rocco","year":"2021","journal-title":"J Trans Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad676","article-title":"Efficacy of bortezomib for treating anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency syndrome","volume":"78","author":"Angkasekwinai","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1086","article-title":"Daratumumab (Anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-gamma autoantibodies","volume":"72","author":"Ochoa","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430179\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:37:26Z","timestamp":1725856646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430179\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2024.1430179"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1430179","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"article-number":"1430179"}}